Filing Details
- Accession Number:
- 0001437749-20-015556
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-22 18:16:00
- Reporting Period:
- 2020-07-20
- Accepted Time:
- 2020-07-22 18:16:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1781127 | Jr Walter John Hanna | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-20 | 11,294 | $2.40 | 85,818 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-20 | 11,294 | $32.05 | 74,524 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-21 | 653 | $2.40 | 75,177 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-21 | 653 | $32.36 | 74,524 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-07-20 | 11,294 | $0.00 | 11,294 | $2.40 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-07-21 | 653 | $0.00 | 653 | $2.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 653 | 2021-09-20 | No | 4 | M | Direct | |
| 0 | 2021-09-20 | No | 4 | M | Direct |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019.
- Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.32. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
- The option is fully vested.
Billionaire Hedge Funds
